Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Helen LeatherJ R Wingard

Abstract

A single-institution, open-label prospective pharmacokinetic evaluation of the interaction between intravenous itraconazole and intravenous cyclosporin A and tacrolimus was conducted in allogeneic hematopoietic stem cell transplant recipients. The study was conducted in 2 phases, with patients acting as their own controls. In phase 1, steady-state concentrations and clearance of cyclosporin A and tacrolimus administered alone were evaluated. Phase 2 evaluated serum concentrations and clearance of cyclosporin A and tacrolimus under the influence of itraconazole therapy. Among 17 patients who completed both phases of the study, the mean increase in the serum tacrolimus concentration was 83% (P<.0001), and the mean increase in the serum cyclosporin A concentration was 80% (P=.0001). There was no correlation between serum itraconazole concentrations and the serum concentrations of tacrolimus or cyclosporin A. The drug interaction between itraconazole and calcineurin inhibitors is predictable and occurs within 48 hours of concomitant drug administration. The data suggest that dose reductions of tacrolimus and cyclosporin A in the range of 50% to 100% are necessary when itraconazole therapy is initiated and that subsequent close moni...Continue Reading

References

Aug 15, 1990·Annals of Internal Medicine·M R KramerJ Theodore
Aug 1, 1987·Lancet·J T KwanA J Eisinger
Dec 5, 1987·Lancet·D TrenkD Birnbaum
May 27, 1994·Transplantation·R MañezT E Starzl
Aug 1, 1994·The American Journal of Medicine·D W DenningA Catanzaro
Feb 25, 1998·Transplantation Proceedings·V FurlanA M Taburet
Jan 13, 1999·Clinical Pharmacokinetics·J M Poirier, G Cheymol
Oct 26, 1999·The Annals of Pharmacotherapy·D CaponeV Basile
Feb 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M NucciW Pulcheri
Mar 10, 2000·Clinical Pharmacokinetics·K VenkatakrishnanD J Greenblatt
Apr 20, 2000·The Annals of Pharmacotherapy·M Outeda MacíasI Martín
Sep 29, 2000·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·T IdeuraK Kiyosawa
Mar 27, 2001·Clinical Transplantation·S L WimberleyS M Gordon
Mar 27, 2001·Transplantation Proceedings·R BanerjeeN R Banner
Jun 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C A DykewiczUNKNOWN American Society of Blood and Marrow Transplantation
Mar 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kieren A MarrLawrence Corey
Jul 29, 2003·Therapeutic Drug Monitoring·Matthew J Cervelli, Graeme R Russ
Dec 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Axel GlasmacherIngo G H Schmidt-Wolf

❮ Previous
Next ❯

Citations

Jun 5, 2012·European Journal of Clinical Pharmacology·Antonio RuggieroRiccardo Riccardi
Aug 8, 2013·Transplantation·Patricia MuñozEmilio Bouza
Aug 18, 2010·Clinical and Experimental Nephrology·Alok SharmaAmit K Dinda
Oct 15, 2011·Expert Opinion on Drug Metabolism & Toxicology·Paul O Gubbins
May 11, 2012·Enfermedades infecciosas y microbiología clínica·Jesús FortúnManuel Cuenca-Estrella
Feb 7, 2012·Enfermedades infecciosas y microbiología clínica·Jesús Fortún
Apr 9, 2011·Enfermedades infecciosas y microbiología clínica·Jesús FortúnUNKNOWN Grupo de Estudio de Micología Médica de la SEIMC (GEMICOMED)
Aug 25, 2009·International Journal of Antimicrobial Agents·Jörg J VehreschildOliver A Cornely
Mar 8, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N SinghUNKNOWN AST Infectious Diseases Community of Practice
Jan 28, 2010·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·N SinghUNKNOWN AST Infectious Diseases Community of Practice
Oct 1, 2009·Biopharmaceutics & Drug Disposition·Akira YokomasuKen-ichi Inui
Dec 17, 2009·Mycoses·Paul O Gubbins, Seth Heldenbrand
May 23, 2012·The Veterinary Journal·Marcel KovalikAdri H M van den Broek
Aug 18, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Xue-Feng LuXiao-Hui Chen
Jun 17, 2008·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Rami B IbrahimDavid J Edwards
Nov 28, 2018·Expert Opinion on Drug Metabolism & Toxicology·Ana PejčićMiloš Milosavljević
Nov 3, 2007·Current Opinion in Infectious Diseases·Paul O Gubbins
Dec 17, 2009·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Victoria K ShanmugamVirginia Steen
May 8, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Sarwat KhalilM Rizwan Sohail
Oct 10, 2019·Expert Opinion on Drug Metabolism & Toxicology·Yuan Gao, Jingjing Ma
Jul 20, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Andreas H GrollRoger J M Brüggemann
Sep 25, 2021·British Journal of Clinical Pharmacology·Ranita KirubakaranSophie L Stocker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Central Nervous System Fungal Infections

Central nervous system fungal infections are rare and typically occur in immunocompromised patients, such as those with HIV infection or transplant recipients. Discover the latest research on central nervous system fungal infections here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.